Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence? – The Lancet

Here, based on pre-pandemic incidence rates from the entire Danish population, we report that the number of venous thromboembolisms reported in relation to the Oxford–AstraZeneca COVID-19 vaccine does not seem to be increased beyond the expected incidence rate.

Source: Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence? – The Lancet